Validate TLR4 priming as actionable driver in gut-brain neurodegeneration axis
Test whether gut microbiome dysbiosis drives neuroinflammation through TLR4 priming. If true, butyrate-restoring interventions should reduce neuroinflammation before neurodegeneration markers improve.